Contingent valuation: what needs to be done?
- 1 January 2010
- journal article
- review article
- Published by Cambridge University Press (CUP) in Health Economics, Policy and Law
- Vol. 5 (1) , 91-111
Abstract
Contingent valuation (CV) has been argued to have theoretical advantages over other approaches for benefit valuation used by health economists. Yet, in reality, the technique appears not to have realised these advantages when applied to health-care issues, such that its influence in decision-making at national levels has been non-existent within the health sector. This is not a result of a lack of methodological work in the area, which has continued to flourish. Rather, it is a result of such activities being undertaken in a rather uncoordinated and unsystematic fashion, leading CV to be akin to a ‘ship without a sail’. This paper utilises a systematic review of the CV literature in health to illustrate some important points concerning the conduct of CV studies, before providing a comment on what the remaining policy and research priorities are for the technique, and proposing a guideline for such studies. It is hoped that this will initiate some wider and rigorous debate on the future of the CV technique in order to make it seaworthy, give it direction and provide the right momentum.Keywords
This publication has 46 references indexed in Scilit:
- On the numerical forms of contingent valuation responsesJournal of Economic Psychology, 2007
- A ???League Table??? of Contingent Valuation Results for Pharmaceutical InterventionsPharmacoEconomics, 2007
- How much are health-care systems prepared to pay to produce a QALY?The European Journal of Health Economics, 2005
- Can we estimate the ‘social’ value of a QALY?: Four core issues to resolveHealth Policy, 2005
- Comparing willingness-to-pay: bidding game format versus open-ended and payment scale formatsHealth Policy, 2004
- Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysisHealth Economics, 2004
- Cost-Effectiveness Analysis and the Consistency of Decision MakingPharmacoEconomics, 2001
- Willingness to Pay for a Quality-adjusted Life YearMedical Decision Making, 2000
- Economic foundations of cost-effectiveness analysisJournal of Health Economics, 1997
- The relationship between cost-effectiveness analysis and cost-benefit analysisSocial Science & Medicine, 1995